A Self‐Administered Behavioral Intervention Using Tailored Messages for Migraine

Abstract

The findings suggest that the SEABIT for migraine prevention is an effective behavioral intervention that potentially could be accessed and distributed in a variety of settings including primary care.

Dynamics of Changes in Self-Efficacy and Locus of Control Expectancies in the Behavioral and Drug Treatment of Severe Migraine

“…Unfortunately, empirical data bearing on these hypotheses for migraine treatment is lacking. Nicholson and colleagues [21] reported no significant increase in internal headache locus of control with self-administered cognitive-behavioral therapy for headache. Although Mizener and colleagues [23] reported a significant increase in the internality of general health locus of control in 11 patients treated with thermal biofeedback for migraine, more than half the patients had dropped out of treatment, and thus were not included in the analysis.…”

“…By definition, even frequent (episodic) migraine is less pervasive than chronic tension-type headache, but more acutely debilitating, and thus the pattern of treatment effects on psychological variables may differ in these two disorders. The three available 1 studies that have examined changes in headache self-efficacy with psychological treatment of migraine have suggested that headache self-efficacy increases substantially with cognitivebehavioral therapy [21,22] and (thermal) biofeedback for migraine [23]. However, these studies suffered from a number of limitations, including the lack of a control or comparison group that would allow changes in headache self-efficacy to be unequivocally attributed to treatment [21,23], the failure to report findings separately for participants with migraine and participants with tension-type headache [21,22], and data from only a small number (N<25) of patients [21,23].…”

Medium-term effectiveness of online behavioral training in migraine self-management: A randomized trial controlled over 10 months

“…Exclusion of participants who used prophylactic medications as recommended for behavioral research (8) did not affect any of the outcomes. A reduction !50% in attack frequency was adopted as clinically significant change or treatment responder rate, in accordance with other studies (12,17,19,20,22). Differences ranging from þ49% to À49% were considered no change, and an increase of !50% was deemed an adverse response.…”

“…10 months after baseline). Most prior studies in oBT (17)(18)(19)(20)(21)(22)(23) were confined to post-training measurement (17)(18)(19)(20)22) four of which yielded significant headache improvement (17,19,20,22) also compared to WLC (17,19) or active control (22). Unfortunately the comparison with two recent oBT studies with control over six months post-training is limited given differences in study group (youngsters aged 12 years on average) (21) and the exclusion of headache as an outcome variable (23).…”

Behavioral treatment of headaches: extending the reach

“…It is likely that certain types of patients will be less responsive to limited contact treatments (such as chronic forms of headache and headache complicated by medication overuse), but this has not received sufficient attention to date. Incorporating messages that are tailored to the specific symptom presentation and progress of patients may lead to even further gains [23].…”